Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors

Journal of Medicinal Chemistry
2011.0

Abstract

Among the four known vasopressin and oxytocin receptors, the specific localization of the V1b isoform is poorly described because of the lack of selective pharmacological tools. In an attempt to address this need, we decided to design, synthesize, and characterize fluorescent selective V1b analogues. Starting with the selective V1b agonist [deamino-Cys(1),Leu(4),Lys(8)]vasopressin (d[Leu(4),Lys(8)]VP) synthesized earlier, we added blue, green, or red fluorophores to the lysine residue at position 8 either directly or by the use of linkers of different lengths. Among the nine analogues synthesized, two exhibited very promising properties. These are d[Leu(4),Lys(Alexa 647)(8)]VP (3) and d[Leu(4),Lys(11-aminoundecanoyl-Alexa 647)(8)]VP (9). They remained full V1b agonists with nanomolar affinity and specifically decorated the plasma membrane of CHO cells stably transfected with the human V1b receptor. These new selective fluorescent peptides will allow the cellular localization of V1b or OT receptor isoforms in native tissues.

Knowledge Graph

Similar Paper

Design, Synthesis, and Pharmacological Characterization of Fluorescent Peptides for Imaging Human V1b Vasopressin or Oxytocin Receptors
Journal of Medicinal Chemistry 2011.0
Synthesis and Characterization of Fluorescent Antagonists and Agonists for Human Oxytocin and Vasopressin V<sub>1</sub><sub>a</sub>Receptors
Journal of Medicinal Chemistry 2002.0
Selective Nonpeptidic Fluorescent Ligands for Oxytocin Receptor: Design, Synthesis, and Application to Time-Resolved FRET Binding Assay
Journal of Medicinal Chemistry 2015.0
Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1 a receptors
European Journal of Medicinal Chemistry 2016.0
Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting the μ-Opioid Receptor
Journal of Medicinal Chemistry 2015.0
Effects of a D-Cys6/L-Cys6 Interchange in Nonselective and Selective Vasopressin and Oxytocin Antagonists
Journal of Medicinal Chemistry 1995.0
Developing Cyclic Opioid Analogues: Fluorescently Labeled Bioconjugates of Biphalin
ACS Medicinal Chemistry Letters 2020.0
Synthesis of oxytocin antagonists containing conformationally constrained amino acids in position 2
Bioorganic &amp; Medicinal Chemistry Letters 1999.0
Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs
Bioorganic &amp; Medicinal Chemistry 2018.0
Design, Synthesis, and Biological Evaluation of Novel Bifunctional C-Terminal-Modified Peptides for δ/μ Opioid Receptor Agonists and Neurokinin-1 Receptor Antagonists
Journal of Medicinal Chemistry 2007.0